Season 1 · Episode 16
S1 Ep16: Analyzing AMD in research, COVID-19-era practice
April 5, 20217m 58s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Mary Elizabeth Hartnett, MD, FACS, FARVO, a distinguished professor in Ophthalmology and Visual Sciences, University of Utah, as well as director of Pediatric Retina at the John A. Moran Eye Center, and Mark Breazzano, MD, a vitreous and retinal surgeon at the Wilmer Eye Institute, Johns Hopkins University, analyze two areas of AMD relevant to today's field:
Dr. Hartnett highlights current research being conducted on the pathophysiology of AMD involving very long chain polyunsaturated fatty acids and new mechanism for fibrosis and neovascular AMD.
Dr. Hartnett highlights current research being conducted on the pathophysiology of AMD involving very long chain polyunsaturated fatty acids and new mechanism for fibrosis and neovascular AMD.
Dr. Breazzano discusses how the COVID-19 pandemic has altered how ophthalmologists treat wet AMD, and how physicians can maximize their patient outcomes.